JAFFER A AJANI to Carcinoma, Transitional Cell
This is a "connection" page, showing publications JAFFER A AJANI has written about Carcinoma, Transitional Cell.
Connection Strength
0.483
-
The role of ramucirumab and pembrolizumab combination in patients with advanced non-small cell lung cancer, gastroesophageal adenocarcinoma, or urothelial carcinoma. Chin Clin Oncol. 2021 Jun; 10(3):30.
Score: 0.445
-
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial. Int J Radiat Oncol Biol Phys. 2013 Nov 15; 87(4):638-45.
Score: 0.017
-
Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol. 1993 Jun; 27(3):209-15.
Score: 0.017
-
Radiotherapy for anal cancer: experience from 1979-1987. Int J Radiat Oncol Biol Phys. 1989 Dec; 17(6):1153-60.
Score: 0.003